Diagnamed Holdings Corp. (DGNMF)

Diagnamed Holdings Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	0.18	0.16	0.61	1.57	2.36
Cash & Short-Term Investments	0.18	0.16	0.61	1.57	2.36
Cash Growth	13.37%	-73.29%	-61.35%	-33.40%	-
Other Receivables	0.02	0.03	0.06	0.05	0.03
Receivables	0.02	0.03	0.06	0.05	0.03
Prepaid Expenses	0.01	0.01	-	-	-
Total Current Assets	0.22	0.2	0.66	1.62	2.39
Total Assets	0.22	0.2	0.66	1.62	2.39
Accounts Payable	0.66	0.46	0.42	0.36	0.15
Accrued Expenses	0.01	0	0	0.01	-
Total Current Liabilities	0.67	0.47	0.43	0.37	0.15
Total Liabilities	0.67	0.47	0.43	0.37	0.15
Common Stock	4.28	3.57	3.57	3.17	3.11
Additional Paid-In Capital	1.54	1.03	1.03	0.15	0.01
Retained Earnings	-6.26	-4.86	-4.36	-3.08	-1.95
Comprehensive Income & Other	-	-	-	1	1.06
Shareholders' Equity	-0.45	-0.27	0.24	1.25	2.24
Total Liabilities & Equity	0.22	0.2	0.66	1.62	2.39
Net Cash (Debt)	0.18	0.16	0.61	1.57	2.36
Net Cash Growth	13.37%	-73.29%	-61.35%	-33.40%	-
Net Cash Per Share	0.00	0.00	0.01	0.02	0.04
Filing Date Shares Outstanding	114.27	80.05	80.05	76.22	76.22
Total Common Shares Outstanding	109.16	80.05	80.05	76.22	75.6
Working Capital	-0.45	-0.27	0.24	1.25	2.24
Book Value Per Share	-0.00	-0.00	0.00	0.02	0.03
Tangible Book Value	-0.45	-0.27	0.24	1.25	2.24
Tangible Book Value Per Share	-0.00	-0.00	0.00	0.02	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.